HIGHLIGHTS
- who: March et al. from the Innsbruck Medical University, Austria have published the paper: CircRNA: A new class of targets for gastric cancer drug resistance therapy, in the Journal: (JOURNAL)
- what: The main reason for the high GC mortality rate is likely due to its diagnosis in the advanced or metastatic stage . Research has shown that autophagy dysregulation may be one of the main reasons for drug resistance in cancer, in which circCPM participates .
- how: The data indicated that circRACGAP1 regulated apatinib-induced autophagy by targeting miR-3657 and ATG7.
- future . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.